Logo image of ST5.DE

STEICO SE (ST5.DE) Stock Fundamental Analysis

FRA:ST5 - Deutsche Boerse Ag - DE000A0LR936 - Common Stock - Currency: EUR

24.8  +0.25 (+1.02%)

Fundamental Rating

4

ST5 gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 20 industry peers in the Building Products industry. ST5 scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ST5 does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year ST5 was profitable.
ST5 had positive earnings in each of the past 5 years.
Each year in the past 5 years ST5 had a positive operating cash flow.
ST5.DE Yearly Net Income VS EBIT VS OCF VS FCFST5.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M

1.2 Ratios

With a Return On Assets value of 1.72%, ST5 is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
ST5 has a Return On Equity of 2.98%. This is in the lower half of the industry: ST5 underperforms 60.00% of its industry peers.
The Return On Invested Capital of ST5 (2.97%) is worse than 65.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ST5 is below the industry average of 9.36%.
Industry RankSector Rank
ROA 1.72%
ROE 2.98%
ROIC 2.97%
ROA(3y)5.17%
ROA(5y)6.61%
ROE(3y)9.53%
ROE(5y)12.21%
ROIC(3y)6.1%
ROIC(5y)7.61%
ST5.DE Yearly ROA, ROE, ROICST5.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

Looking at the Profit Margin, with a value of 2.73%, ST5 is in line with its industry, outperforming 50.00% of the companies in the same industry.
In the last couple of years the Profit Margin of ST5 has declined.
Looking at the Operating Margin, with a value of 6.50%, ST5 is in line with its industry, outperforming 45.00% of the companies in the same industry.
ST5's Operating Margin has declined in the last couple of years.
ST5 has a Gross Margin of 46.78%. This is comparable to the rest of the industry: ST5 outperforms 60.00% of its industry peers.
In the last couple of years the Gross Margin of ST5 has remained more or less at the same level.
Industry RankSector Rank
OM 6.5%
PM (TTM) 2.73%
GM 46.78%
OM growth 3Y-18.5%
OM growth 5Y-4.49%
PM growth 3Y-25.89%
PM growth 5Y-9.04%
GM growth 3Y1.37%
GM growth 5Y1.39%
ST5.DE Yearly Profit, Operating, Gross MarginsST5.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ST5 is destroying value.
Compared to 1 year ago, ST5 has about the same amount of shares outstanding.
Compared to 5 years ago, ST5 has less shares outstanding
The debt/assets ratio for ST5 has been reduced compared to a year ago.
ST5.DE Yearly Shares OutstandingST5.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M
ST5.DE Yearly Total Debt VS Total AssetsST5.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

An Altman-Z score of 2.59 indicates that ST5 is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of ST5 (2.59) is comparable to the rest of the industry.
ST5 has a Debt/Equity ratio of 0.48. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.48, ST5 is in the better half of the industry, outperforming 65.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF N/A
Altman-Z 2.59
ROIC/WACC0.46
WACC6.39%
ST5.DE Yearly LT Debt VS Equity VS FCFST5.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

ST5 has a Current Ratio of 6.92. This indicates that ST5 is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of ST5 (6.92) is better than 100.00% of its industry peers.
A Quick Ratio of 4.54 indicates that ST5 has no problem at all paying its short term obligations.
ST5's Quick ratio of 4.54 is amongst the best of the industry. ST5 outperforms 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 6.92
Quick Ratio 4.54
ST5.DE Yearly Current Assets VS Current LiabilitesST5.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M

3

3. Growth

3.1 Past

The earnings per share for ST5 have decreased strongly by -62.38% in the last year.
Measured over the past years, ST5 shows a decrease in Earnings Per Share. The EPS has been decreasing by -3.27% on average per year.
The Revenue has been growing slightly by 5.05% in the past year.
Measured over the past years, ST5 shows a small growth in Revenue. The Revenue has been growing by 6.01% on average per year.
EPS 1Y (TTM)-62.38%
EPS 3Y-26.28%
EPS 5Y-3.27%
EPS Q2Q%-44.68%
Revenue 1Y (TTM)5.05%
Revenue growth 3Y-1.03%
Revenue growth 5Y6.01%
Sales Q2Q%4.32%

3.2 Future

The Earnings Per Share is expected to decrease by -1.44% on average over the next years.
The Revenue is expected to grow by 4.94% on average over the next years.
EPS Next Y-23.57%
EPS Next 2Y-1.44%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.43%
Revenue Next 2Y5.4%
Revenue Next 3Y6.13%
Revenue Next 5Y4.94%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
ST5.DE Yearly Revenue VS EstimatesST5.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 100M 200M 300M 400M 500M
ST5.DE Yearly EPS VS EstimatesST5.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 33.51, ST5 can be considered very expensive at the moment.
ST5's Price/Earnings ratio is in line with the industry average.
When comparing the Price/Earnings ratio of ST5 to the average of the S&P500 Index (26.51), we can say ST5 is valued slightly more expensively.
With a Price/Forward Earnings ratio of 14.42, ST5 is valued correctly.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ST5 indicates a somewhat cheap valuation: ST5 is cheaper than 75.00% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 34.09. ST5 is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 33.51
Fwd PE 14.42
ST5.DE Price Earnings VS Forward Price EarningsST5.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as ST5.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.48
ST5.DE Per share dataST5.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.44%
EPS Next 3YN/A

1

5. Dividend

5.1 Amount

With a yearly dividend of 0.84%, ST5 is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.95, ST5 is paying slightly less dividend.
Compared to an average S&P500 Dividend Yield of 2.40, ST5's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.84%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
ST5.DE Yearly Dividends per shareST5.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2025 0 0 0 0 0

5.3 Sustainability

DPN/A
EPS Next 2Y-1.44%
EPS Next 3YN/A
ST5.DE Yearly Income VS Free CF VS DividendST5.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

STEICO SE

FRA:ST5 (8/11/2025, 12:43:16 PM)

24.8

+0.25 (+1.02%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)07-21 2025-07-21
Earnings (Next)10-20 2025-10-20
Inst Owners11.27%
Inst Owner ChangeN/A
Ins Owners10.1%
Ins Owner ChangeN/A
Market Cap349.18M
Analysts77.14
Price Target28.22 (13.79%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.84%
Yearly Dividend0
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.75%
PT rev (3m)-5.68%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.43%
Revenue NY rev (3m)-0.31%
Valuation
Industry RankSector Rank
PE 33.51
Fwd PE 14.42
P/S 0.91
P/FCF N/A
P/OCF N/A
P/B 0.99
P/tB 1
EV/EBITDA 7.48
EPS(TTM)0.74
EY2.98%
EPS(NY)1.72
Fwd EY6.94%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS27.31
BVpS25
TBVpS24.91
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.72%
ROE 2.98%
ROCE 4.26%
ROIC 2.97%
ROICexc 2.97%
ROICexgc 2.98%
OM 6.5%
PM (TTM) 2.73%
GM 46.78%
FCFM N/A
ROA(3y)5.17%
ROA(5y)6.61%
ROE(3y)9.53%
ROE(5y)12.21%
ROIC(3y)6.1%
ROIC(5y)7.61%
ROICexc(3y)6.47%
ROICexc(5y)8.18%
ROICexgc(3y)6.49%
ROICexgc(5y)8.23%
ROCE(3y)8.74%
ROCE(5y)10.91%
ROICexcg growth 3Y-29.03%
ROICexcg growth 5Y-9.98%
ROICexc growth 3Y-28.82%
ROICexc growth 5Y-9.94%
OM growth 3Y-18.5%
OM growth 5Y-4.49%
PM growth 3Y-25.89%
PM growth 5Y-9.04%
GM growth 3Y1.37%
GM growth 5Y1.39%
F-ScoreN/A
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF N/A
Debt/EBITDA 2.46
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.92
Quick Ratio 4.54
Altman-Z 2.59
F-ScoreN/A
WACC6.39%
ROIC/WACC0.46
Cap/Depr(3y)252.85%
Cap/Depr(5y)257.2%
Cap/Sales(3y)17.35%
Cap/Sales(5y)17.48%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-62.38%
EPS 3Y-26.28%
EPS 5Y-3.27%
EPS Q2Q%-44.68%
EPS Next Y-23.57%
EPS Next 2Y-1.44%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)5.05%
Revenue growth 3Y-1.03%
Revenue growth 5Y6.01%
Sales Q2Q%4.32%
Revenue Next Year4.43%
Revenue Next 2Y5.4%
Revenue Next 3Y6.13%
Revenue Next 5Y4.94%
EBIT growth 1Y-46.09%
EBIT growth 3Y-19.34%
EBIT growth 5Y1.26%
EBIT Next Year59.31%
EBIT Next 3Y24.01%
EBIT Next 5YN/A
FCF growth 1Y190.91%
FCF growth 3Y41.56%
FCF growth 5YN/A
OCF growth 1Y13.46%
OCF growth 3Y-11.72%
OCF growth 5Y6.35%